| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |